Author

Gottfried Novacek 1

1 Medi

A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Wan J Le

ADALIMUMAB (ADA) AND INFLIXIMAB (IFX) THERAPY DURING PREGNANCY IN IBD: A PROSPECTIVE ASSESSMENT OF OUTCOME, SAFETY, ANTI-TNFΑ CORD BLOOD AND FOLLOW UP BLOOD LEVELS IN NEWBORNS

Stefan Traussnigg, Alexander Eser, Christian Primas, Pavol Papay, Cornelia Gratzer, Andrea Mikulits, Sieglinde Reinisch, Walter Reinisch, Michael Trauner, Harald Vogelsang, Gottfried Novacek, Clemens Dejaco

ANTI-DRUG ANTIBODIES INHIBIT NEUTRALIZATION OF TNF-ALPHA IN INFLIXIMAB TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Alexander Eser, Harald Vogelsang, Sieglinde Reinisch, Gottfried Novacek, Clemens Dejaco, Lili Kazemi-Shirazi, Christian Primas, Sonja Brehovsky, Xinjun Liu, Sharat Singh, Walter Reinisch

ASSOCIATION BETWEEN ELEVEN THIOPURINE METABOLITES AND MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE

Sieglinde Reinisch, Ute Hofmann, Cornelia Lichtenberger, Stefan Winter, Alexander Eser, Alexander Teml, Clemens Dejaco, Gottfried Novacek, Harald Vogelsang, Elke Schäffeler, Matthias Schwab, Walter Reinisch

DIAGNOSTIC DELAY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A STUDY OF THE AUSTRIAN IBD STUDY GROUP (ATISG)

Gottfried Novacek, Hans Peter Gröchenig, Thomas Haas, Heimo Helmut Wenzl, Pius Steiner, Robert Koch, Thomas Feichtenschlager, Gerald Eckhardt, Andreas Mayer, Andreas Kirchgatterer, Othmar Ludwiczek, Reingard Platzer, Pavol Papay, Johanna Gartner, Harry Fuchssteiner, Wolfgang Miehsler, Paul-Gerhard Peters, Gerhard Reicht,

EFFICACY AND SAFETY OF GASTRO-RESISTANT PHOSPHATIDYLCHOLINE (LT-02) FOR INDUCTION OF REMISSION IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS REFRACTORY TO MESALAZINE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (PCG-2)

Axel Dignass, Walter Reinisch, Marek Horyński, Oleksandr Poyda, Peter Armerding, Jost Langhorst, Klaus Fellermann, Tanja Kühbacher, Gottfried Novacek, Peter Hasselblatt, Jürgen Stein, Peter Übel, Heidrun Heinemann, Ralph Mueller, Roland Greinwald, Wolfgang Stremmel

EFFICACY AND SAFETY OF TRICHURIS SUIS OVA FOR TREATMENT OF MILDLY-TO-MODERATELY ACTIVE CROHN’S DISEASE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY

Jürgen Schölmerich, K. Fellermann, Frank Seibold, Gerhard Rogler, Jost Langhorst, Stefanie Howaldt, Gottfried Novacek, A. Petersen, Oliver Bachmann, H. Matthes, N. Hesselbarth, T. Klugmann, J. Wehkamp, J. Klaus, Claudia Ott, K. Dilger, Roland Greinwald, R. Mueller

INFLIXIMAB AND ADALIMUMAB IN TNF-ΑNAÏVE CROHN`S DISEASE PATIENTS: AUSTRIAN MULTICENTRE COHORT STUDY

Pavol Papay, Stephanie Kainz, Wolfgang Petritsch, Thomas Haas, Thomas Feichtenschlager, Gottfried Novacek, Alexander Eser, Harald Vogelsang, Walter Reinisch

INFORMATION NECESSARY TO PREDICT INDIVIDUAL INFLIXIMAB (IFX) PHARMACOKINETICS (PK) IN PATIENTS WITH IBD

Alexander Eser, Harald Vogelsang, Gottfried Novacek, Sieglinde Reinisch, Christian Primas, Sonja Brehovsky, Diane R. Mould, Walter Reinisch

SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Z

Item 1 - 10 / 20
1
2